Senior Financial Analyst Corporate Finance (M&A and BD)

Exelixis•Alameda, CA

1d•$116,000 - $166,000•Onsite

About The Position

The Senior Financial Analyst - BD and M&A will be responsible for the execution of financial analysis to support the executive leadership team on critical business decisions. This role will perform duties to support corporate development, business development, strategic planning, life cycle management and general corporate finance activities.

Requirements

BS/BA degree in related discipline and 5 years of related experience; or MBA degree in related discipline and 3 year of related experience; or, Equivalent combination of education and experience
Strong expertise in financial modeling and financial statement analysis (GAAP and non-GAAP)
Advanced knowledge of Excel, PowerPoint, FactSet (or comparable financial analytics tools e.g., Bloomberg, Capital IQ)
Advanced Excel modelling
Expertise in evaluating and modeling various funding arrangements (e.g., revolver, term loans, equity issuances, etc.)
Strong analytical, strategic, problem solving and organizational skills
Strong attention to detail
Strong communication (verbal and written) and presentation skills
Knowledgeable about the biotech / pharma industry
Adaptability to evolving business needs, priorities, and approaches
Ability to effectively manage multiple projects and competing priorities
Demonstrated understanding of operational drivers of the financial analyses
Ability to translate financial analyses into clear business implications and communicate them effectively to cross-functional teams and leadership
Ability to navigate ambiguity and perform analyses in situations with incomplete information and evolving assumptions

Nice To Haves

Experience in investment banking/management consulting preferred
Experience in Biotech/Pharmaceutical industry preferred
Experience working with cross-functional teams is a plus

Responsibilities

Prepare company/asset valuation analyses on potential licensing and M&A transactions
Build merger consequences models to evaluate potential acquisitions
Evaluate in-licensing opportunities from a financial/business perspective
Test sensitivity of deal economics to variances in key assumptions, including synergies
Contribute to preparation and presentation of deal summaries and recommendations to senior management
Build and update long-range planning models and assist in preparation of BoD presentations
Perform discounted cash flow analyses to support lifecycle management of pipeline assets
Perform company-level and project-level valuation analysis
Perform specific value-added analyses, e.g., resource allocation, profitability analysis, sensitivity/scenario analyses, benchmarking
Evaluate and compare the financial benefits of life cycle management initiatives/alternatives
Build analysis to support business partner recommendations on investment/divestment decisions to executive management and Board of Directors
Build and maintain effective relationships with cross-functional stakeholders to support collaboration, alignment, and successful execution of business priorities
Develop and standardize financial analysis models employing best-in-class financial analysis techniques, including scenario modelling
Assist in development of cost-effective strategies for financing the company's business initiatives and optimizing the company's capital structure
Performs comparable company analysis on biotechnology peers in a broad number of areas including financings, capital structure, deal-making, share performance, etc.
Create company profiles on biotech and pharma peers
Maintain corporate weighted average cost of capital (WACC) calculation
Proactively monitors industry news, trends, and market dynamics
Performs other duties as assigned
Complies with all policies and standards